Improve Medical Instruments Co., Ltd. (300030.SZ)
300030.SZ Stock Price Chart
Explore Improve Medical Instruments Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300030.SZ price movements and trends.
300030.SZ Company Profile
Discover essential business fundamentals and corporate details for Improve Medical Instruments Co., Ltd. (300030.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
25 Dec 2009
Employees
936.00
Website
https://www.improve-medical.comCEO
Guanhua Deng
Description
Improve Medical Instruments Co., Ltd. provides technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. Its principal products include IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, etc. The company also provides blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, blood collection tube preparation systems, graphic user interface devices, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. Improve Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Guangzhou, China.
300030.SZ Financial Timeline
Browse a chronological timeline of Improve Medical Instruments Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
EPS came in at ¥0.03 , while revenue for the quarter reached ¥115.42M .
Earnings released on 21 May 2025
EPS came in at -¥0.26 , while revenue for the quarter reached ¥159.86M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.03 , while revenue for the quarter reached ¥115.54M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.12 , while revenue for the quarter reached ¥128.31M .
Earnings released on 29 Jun 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥150.32M .
Earnings released on 21 May 2024
EPS came in at -¥0.21 , while revenue for the quarter reached ¥172.22M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥141.15M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.02 , while revenue for the quarter reached ¥152.64M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥161.20M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.04 , while revenue for the quarter reached ¥158.56M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.43 , while revenue for the quarter reached ¥181.22M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.07 , while revenue for the quarter reached ¥177.12M .
Dividend declared on 6 Jul 2022
A dividend of ¥0.04 per share was announced, adjusted to ¥0.04. The dividend was paid on 6 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥172.88M .
Earnings released on 31 Mar 2022
EPS came in at -¥0.12 , while revenue for the quarter reached ¥179.56M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.05 , while revenue for the quarter reached ¥210.17M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.19 , while revenue for the quarter reached ¥173.42M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.19 , while revenue for the quarter reached ¥185.67M .
Dividend declared on 11 Jun 2021
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 11 Jun 2021.
Earnings released on 21 Apr 2021
EPS came in at -¥0.15 , while revenue for the quarter reached ¥296.53M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥230.57M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.33 , while revenue for the quarter reached ¥220.87M .
300030.SZ Stock Performance
Access detailed 300030.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.